Save your place

Sign in to WhoBought

Please try again later.

Avalo Therapeutics, Inc. (AVTX) institutional ownership

Latest close $19.52 Jul 28, 2026
Market cap$85M 52-week range SectorHealthcare
Funds holding · Q4 2023
27
reported AVTX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q4 2023
Activity unavailable N/A
0 buyers · 27 sellers

Avalo Therapeutics, Inc. (AVTX) price and institutional activity

Dates

Q4 2023

$0 bought by 0 investors
$0 sold by 27 investors
Acadian Asset Management LLCVirtu Financial LLC +25 more
Bought Sold Totals per quarter; hover a bar for the names.

Avalo Therapeutics, Inc. (AVTX) institutional activity · 27

Investor Type Est. change Change Δ Own Date
Acadian Asset Management LLC · Exited
Change −283K Δ Own −100.0% Date Q4 2023
Acadian Asset Management LLC Exited· Q4 2023 −283K −100.0% Q4 2023
Virtu Financial LLC · Exited
Change −185K Δ Own −100.0% Date Q4 2023
Virtu Financial LLC Exited· Q4 2023 −185K −100.0% Q4 2023
Baader Bank Aktiengesellschaft · Exited
Change −184K Δ Own −100.0% Date Q4 2023
Baader Bank Aktiengesellschaft Exited· Q4 2023 −184K −100.0% Q4 2023
Geode · Exited
Change −134K Δ Own −100.0% Date Q4 2023
Geode Exited· Q4 2023 −134K −100.0% Q4 2023
Vanguard · Exited
Change −129K Δ Own −100.0% Date Q4 2023
Vanguard Exited· Q4 2023 −129K −100.0% Q4 2023
BlackRock · Exited
Change −105K Δ Own −100.0% Date Q4 2023
BlackRock Exited· Q4 2023 −105K −100.0% Q4 2023
Banque Cantonale Vaudoise · Exited
Change −81K Δ Own −100.0% Date Q4 2023
Banque Cantonale Vaudoise Exited· Q4 2023 −81K −100.0% Q4 2023
Tower Research Capital LLC (trc) · Exited
Change −50K Δ Own −100.0% Date Q4 2023
Tower Research Capital LLC (trc) Exited· Q4 2023 −50K −100.0% Q4 2023
Level Four Advisory Services, LLC · Exited
Change −36K Δ Own −100.0% Date Q4 2023
Level Four Advisory Services, LLC Exited· Q4 2023 −36K −100.0% Q4 2023
Jane Street Group, LLC · Exited
Change −27K Δ Own −100.0% Date Q4 2023
Jane Street Group, LLC Exited· Q4 2023 −27K −100.0% Q4 2023
State Street · Exited
Change −26K Δ Own −100.0% Date Q4 2023
State Street Exited· Q4 2023 −26K −100.0% Q4 2023
Susquehanna International Group, LLP · Exited
Change −23K Δ Own −100.0% Date Q4 2023
Susquehanna International Group, LLP Exited· Q4 2023 −23K −100.0% Q4 2023
Mariner, LLC · Exited
Change −19K Δ Own −100.0% Date Q4 2023
Mariner, LLC Exited· Q4 2023 −19K −100.0% Q4 2023
Xtx Topco Ltd · Exited
Change −18K Δ Own −100.0% Date Q4 2023
Xtx Topco Ltd Exited· Q4 2023 −18K −100.0% Q4 2023
Two Sigma Securities, LLC · Exited
Change −16K Δ Own −100.0% Date Q4 2023
Two Sigma Securities, LLC Exited· Q4 2023 −16K −100.0% Q4 2023
Data through Q4 2023 · filed Feb 10, 2024
15 of 27

Famous investor activity in Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics, Inc. (AVTX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Doyle Mittie · Officer Sell −$93K
Price $20.00 Qty −5K Owned 52K ΔOwn −8.2% Trade date Jun 30, 2026 Filed date Jul 2, 2026
Doyle Mittie Officer Sell $20.00 −5K −$93K 52K −8.2% Jun 30, 2026 Jul 2, 2026
Doyle Mittie · Officer 4 operations 0
Price $8.04–$12.65 Owned 115K Trade date Jun 30, 2026 Filed date Jul 2, 2026
Doyle Mittie Officer 4 operations $8.04–$12.65 0 115K Jun 30, 2026 Jul 2, 2026
Philip Ron M. · Director Grant (A) $1K
Price $15.04 Qty 69 Owned 69 Trade date Jun 30, 2026 Filed date Jul 2, 2026
Philip Ron M. Director Grant (A) $15.04 69 $1K 69 Jun 30, 2026 Jul 2, 2026
Lind Kevin Robert · Director Grant (A) $17K
Price $15.04 Qty 1K Owned 1K Trade date Jun 30, 2026 Filed date Jul 2, 2026
Lind Kevin Robert Director Grant (A) $15.04 1K $17K 1K Jun 30, 2026 Jul 2, 2026
Jain Rita · Director Grant (A) $16K
Price $15.04 Qty 1K Owned 1K Trade date Jun 30, 2026 Filed date Jul 2, 2026
Jain Rita Director Grant (A) $15.04 1K $16K 1K Jun 30, 2026 Jul 2, 2026
Doyle Mittie · Officer Sell −$26K
Price $18.00 Qty −1K Owned 52K ΔOwn −2.7% Trade date Jun 23, 2026 Filed date Jun 25, 2026
Doyle Mittie Officer Sell $18.00 −1K −$26K 52K −2.7% Jun 23, 2026 Jun 25, 2026
Doyle Mittie · Officer 2 operations 0
Price $8.04 Owned 117K Trade date Jun 23, 2026 Filed date Jun 25, 2026
Doyle Mittie Officer 2 operations $8.04 0 117K Jun 23, 2026 Jun 25, 2026
Philip Ron M. · Director Grant (A) 40K
Owned 40K Trade date Jun 23, 2026 Filed date Jun 25, 2026
Philip Ron M. Director Grant (A) 40K 40K Jun 23, 2026 Jun 25, 2026
Riley Jennifer · Officer Tax withholding or exercise payment (F) -$8K
Price $13.10 Qty -588 Owned 40K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Riley Jennifer Officer Tax withholding or exercise payment (F) $13.10 -588 -$8K 40K Jun 10, 2026 Jun 12, 2026
Varki Paul · Officer Tax withholding or exercise payment (F) -$14K
Price $13.10 Qty -1K Owned 33K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Varki Paul Officer Tax withholding or exercise payment (F) $13.10 -1K -$14K 33K Jun 10, 2026 Jun 12, 2026
Sullivan Christopher Ryan · CFO Tax withholding or exercise payment (F) -$2K
Price $13.10 Qty -138 Owned 41K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Sullivan Christopher Ryan CFO Tax withholding or exercise payment (F) $13.10 -138 -$2K 41K Jun 10, 2026 Jun 12, 2026
Doyle Mittie · Officer Tax withholding or exercise payment (F) -$14K
Price $13.10 Qty -1K Owned 52K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Doyle Mittie Officer Tax withholding or exercise payment (F) $13.10 -1K -$14K 52K Jun 10, 2026 Jun 12, 2026
Lind Kevin Robert · Director Grant (A) 20K
Owned 20K Trade date Jun 2, 2026 Filed date Jun 4, 2026
Lind Kevin Robert Director Grant (A) 20K 20K Jun 2, 2026 Jun 4, 2026
Truex Samantha · Director Grant (A) 20K
Owned 20K Trade date Jun 2, 2026 Filed date Jun 4, 2026
Truex Samantha Director Grant (A) 20K 20K Jun 2, 2026 Jun 4, 2026
Kaplan Gilla · Director Grant (A) 20K
Owned 20K Trade date Jun 2, 2026 Filed date Jun 4, 2026
Kaplan Gilla Director Grant (A) 20K 20K Jun 2, 2026 Jun 4, 2026
15 of 65
15 of 65 Sign in to continue to older insider transactions.

Avalo Therapeutics, Inc. (AVTX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
FMR LLC 2.9M
% of shares outstanding 12.6% Filing date May 6, 2026
FMR LLC 2.9M 12.6% May 6, 2026
Commodore Capital LP 5.7M
% of shares outstanding 9.9% Filing date Jun 18, 2026
Commodore Capital LP 5.7M 9.9% Jun 18, 2026
Ra Capital Management, L.P. 2.5M
% of shares outstanding 9.9% Filing date May 15, 2026
Ra Capital Management, L.P. 2.5M 9.9% May 15, 2026
T. Rowe Price Investment Management, Inc. 2.2M
% of shares outstanding 9.5% Filing date May 15, 2026
T. Rowe Price Investment Management, Inc. 2.2M 9.5% May 15, 2026
Tcg Crossover Gp Ii, LLC 3.0M
% of shares outstanding 7.9% Filing date May 12, 2026
Tcg Crossover Gp Ii, LLC 3.0M 7.9% May 12, 2026
Caligan Partners LP 1.6M
% of shares outstanding 7.2% Filing date May 15, 2026
Caligan Partners LP 1.6M 7.2% May 15, 2026
Blackrock, Inc. 3.4M
% of shares outstanding 6.5% Filing date Jul 27, 2026
Blackrock, Inc. 3.4M 6.5% Jul 27, 2026
FMR LLC 3.2M
% of shares outstanding 6.1% Filing date Jun 5, 2026
FMR LLC 3.2M 6.1% Jun 5, 2026
8 of 16

Avalo Therapeutics, Inc. (AVTX) ownership FAQ

Who owns AVTX?

27 reporting institutions disclosed AVTX position changes in the Q4 2023 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q4 2023.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.